Harrisburg, PA – July 18, 2017. The Life Sciences Greenhouse of Central Pennsylvania (LSGPA) announced today an additional investment of $500,000 in MacuLogix, Inc. The investment was part of a syndicate with other, unnamed investors and brings LSGPA’s total investment in the Middletown-based firm to over $2 million.
LLANTRISANT, Wales, June 21, 2017 /PRNewswire/ —
Purolite Life Sciences, a leading provider of specialty resins, and ChromaTan Corporation, a single-use chromatography solutions provider, today announce a successful collaboration for the development and commercialisation of a custom-designed, novel Protein A resin bead designed specifically to address the needs of continuous manufacturing.
The new resin bead exploits the capabilities of ChromaTan’s Continuous Countercurrent Tangential Chromatography (CCTC) system – the first resin-based, column-free chromatography system – to provide up to 15x increases in productivity for Protein A capture, intermediate and polishing steps.
Micro Interventional Devices, Inc. Wins CRT 2017’s “Top Cardiovascular Innovation Award” for MIA(TM), Minimally Invasive Annuloplasty Technology
World’s first annuloplasty system for mitral and tricuspid repair incorporating proprietary PolyCor(TM) and MyoLast(TM) technologies.
Newtown, PA – March 2, 2017 – Micro Interventional Devices, Inc™ (MID), is pleased to announce that it is the recipient of the CRT 2017 “Top Cardiovascular Innovation Award” for the company’s MIA technology. The award was presented to Michael Whitman, MID’s Founder, President and CEO, during the 20th annual CRT meeting on Tuesday, February 21st. [Read more…]
Tests can lead to early identification of Alzheimer’s Disease
Bethlehem, PA–(BUSINESS WIRE)–January 18, 2017– Saladax Biomedical, Inc., a privately held company focused on precision in-vitro diagnostic tests, announced today that it has signed an agreement to license diagnostic tests for Alzheimer’s disease (AD) to Siemens Healthineers. Saladax’s tests identify the amyloid beta 1-42 and tau biomarkers in cerebrospinal fluid (CSF) which are known and accepted biomarkers for AD. [Read more…]
Stephanie Reisinger has worked in Harrisburg’s science and tech sector for over 16 years. In that time, she has experienced firsthand the benefits that the area can offer science and tech-focused companies. [Read more…]